KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Return on Invested Capital (2019 - 2024)

Historic Return on Invested Capital for BioNTech SE (BNTX) over the last 7 years, with Q3 2025 value amounting to 0.49%.

  • BioNTech SE's Return on Invested Capital fell 2400.0% to 0.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49%, marking a year-over-year decrease of 2400.0%. This contributed to the annual value of 1.39% for FY2024, which is 24600.0% down from last year.
  • Latest data reveals that BioNTech SE reported Return on Invested Capital of 0.49% as of Q3 2025, which was down 2400.0% from 0.44% recorded in Q2 2025.
  • BioNTech SE's Return on Invested Capital's 5-year high stood at 42.64% during Q3 2021, with a 5-year trough of 1.37% in Q1 2024.
  • Over the past 5 years, BioNTech SE's median Return on Invested Capital value was 0.76% (recorded in 2023), while the average stood at 4.05%.
  • In the last 5 years, BioNTech SE's Return on Invested Capital surged by 357400bps in 2021 and then tumbled by -417800bps in 2022.
  • Over the past 5 years, BioNTech SE's Return on Invested Capital (Quarter) stood at 2.09% in 2021, then crashed by -57bps to 0.89% in 2022, then crashed by -34bps to 0.59% in 2023, then plummeted by -256bps to 0.92% in 2024, then soared by 47bps to 0.49% in 2025.
  • Its Return on Invested Capital stands at 0.49% for Q3 2025, versus 0.44% for Q2 2025 and 0.65% for Q1 2025.